First Approval for Immunotherapy for Esophageal Cancer First Approval for Immunotherapy for Esophageal Cancer

Esophageal cancer has now joined the list of tumor types that can be treated with a checkpoint inhibitor — in this case, with pembrolizumab (Keytruda).FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news